A global platform advancing pharmaceutical collaboration, innovation, and exports—powering healthcare and connecting markets worldwide
Elevidys is currently the only approved gene therapy that targets the root cause of Duchenne
This year, the OCTF focused on preparing a white paper on oral cancer elimination in India and updating its annual consensus guidelines
The purpose of this investment is to meet the expenditure relating to the civil works to be undertaken for setting up of a manufacturing facility
3SBio will receive a payment of $1.25 billion. Pfizer will also make a $100 million equity investment in 3SBio
Combined strength of two brands across 11 states to elevate patient care delivery and access to doctors
The phase III ARNASA study did not meet the primary endpoint of a statistically significant reduction in the AER at 52 weeks
During Q1FY26, the company incurred Capex of ~Rs. 48.5 crores mainly towards capacity expansion, backward integration and finished formulation R&D
Clinical data showing unprecedented remission rates in newly diagnosed AML patients support advancing ICT01 into pivotal trials
European Commission granted approval of darolutamide in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer (mHSPC)
Subscribe To Our Newsletter & Stay Updated
